Clinical Observation on Budesonide Inhalation in Treatment of Chronic Asthmatic Bronchitis
Yuzhe Li
Abstract
Yuzhe Li
Abstract
Objective:To observe the clinical efficacy of budesonide inhalation in treating patients with chronic asthmatic bronchitis. Methods: Fifty-three patients with chronic asthmatic bronchitis were randomly divided into budesonide group (29 cases) and control group (24 cases). On the basis of anti-infectious and antiasthmatic treatment, patients in budesonide group were given budesonide inhalation for 6 weeks. FEV_(1), FVC, FEV_1/FVC%, PEF were detected before and after treatment in all cases. The clinical efficacy was observed. Results: The clinical symptoms in budesonide group showed no significant improvement (P(0.05)). It showed significant improvement in FEV_(1), FVC, FEV_(1)/FVC%, (P(0.05)), but not in PEF. There is no significant changes in control group (P(0.05)). Conclusion: Budesonide inhalation can significantly improve pulmonary function in patients with chronic asthmatic bronchitis, but no short-term clinical beneficial effect was observed.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the clinical efficacy of budesonide inhalation in treating patients with chronic asthmatic bronchitis. Methods: Fifty-three patients with chronic asthmatic bronchitis were randomly divided into budesonide group (29 cases) and control group (24 cases). On the basis of anti-infectious and antiasthmatic treatment, patients in budesonide group were given budesonide inhalation for 6 weeks. FEV_(1), FVC, FEV_1/FVC%, PEF were detected before and after treatment in all cases. The clinical efficacy was observed. Results: The clinical symptoms in budesonide group showed no significant improvement (P(0.05)). It showed significant improvement in FEV_(1), FVC, FEV_(1)/FVC%, (P(0.05)), but not in PEF. There is no significant changes in control group (P(0.05)). Conclusion: Budesonide inhalation can significantly improve pulmonary function in patients with chronic asthmatic bronchitis, but no short-term clinical beneficial effect was observed.
Key concepts: Budesonide, Medicine, Inhalation, Chronic bronchitis, Bronchitis, Asthma, Internal medicine, Clinical efficacy